All stock reports

NUVAMA evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-24T23:41:00.586664+00:00

Metrics

latest_annual_period
2026-03-31
revenue
46798600000.0
net_income
10410400000.0
operating_cash_flow
20352100000.0
free_cash_flow
20065300000.0
total_assets
344912700000.0
total_liabilities
303681200000.0
total_equity
41209400000.0
cash
219711200000.0
total_debt
115435200000.0
revenue_growth
1.1873185943533708
earnings_growth
0.05563414201333439
net_margin
0.22245109896449894
roe
0.2526219745980286
debt_to_equity
2.801186137143467
cash_conversion
1.954977714593099
free_cash_flow_margin
0.42875855260627455
trailing_pe
32.2709
forward_pe
0.0
peg_ratio
Not supplied
price_to_book
8.0962
dividend_yield
0.0156

Other positional research

No qualifying opportunity

No candidate at another positional horizon in the coherent source run.

  • No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
Decision ID
decision-4f9c6f8944556c83a4888b7b72ad5f082011b7918fe8e34cfae4a657720b6ce2
Policy
stock-decisions-v1
Evidence bundle hash
ed96ae06f5adbb63d4206f5a6510591e1caa4e119dc4af0a45a251669740a938
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: f042d98eaff19b7ed0570eaa2a55bd89d7f2b37237885c19ce49ea15fc417f0b
  • daily-price: 3d4f5d071dc08aa995fc4d7c516dd87eebf4f3f5bb851a2b56db0003a56bd43f
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Numerical report available. Evidence briefing is queued or awaiting retry.

Cached observations and evidence limits